| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 81 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 53 |
| 2 | TACROLIMUS OINTMENT 0.1% | 53 |
| 3 | MYCOPHENOLATE MOFETIL | 48 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 48 |
| 5 | PREDNISONE | 26 |
| 6 | METHYLPREDNISOLONE | 25 |
| 7 | BEVACIZUMAB | 24 |
| 8 | PREDNISOLONE | 20 |
| 9 | PREDNISOLONE ORAL | 20 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | THROMBIN HUMAN AND FIBRINOGEN | 5 | 0.0149 |
| 1 | ETHIODIZED OIL | 3 | 0.0023 |
| 2 | AMPICILLIN AND SULBACTAM | 2 | 0.0023 |
| 3 | CEFOTAXIME INJECTION | 4 | 0.0009 |
| 4 | AMPICILLIN SODIUM AND SULBACTAM SODIUM | 2 | 0.0008 |
| 5 | VALGANCICLOVIR | 12 | 0.0006 |
| 6 | TACROLIMUS | 81 | 0.0005 |
| 7 | TIGECYCLINE | 3 | 0.0005 |
| 8 | VANCOMYCIN HYDROCHLORIDE | 4 | 0.0005 |
| 9 | RAMUCIRUMAB | 3 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Blood Coagulation Factor [EPC] | 5 | 0.0061 |
| 1 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 2 | Humanized Monoclonal Antibody Fragment [EPC] | 1 | 0.0007 |
| 3 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 13 | 0.0006 |
| 4 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 3 | 0.0005 |
| 5 | Tetracycline-class Antibacterial [EPC] | 3 | 0.0004 |
| 6 | Echinocandin Antifungal [EPC] | 3 | 0.0004 |
| 7 | Anthelmintic [EPC] | 1 | 0.0003 |
| 8 | Antimalarial [EPC] | 3 | 0.0003 |
| 9 | Antiprotozoal [EPC] | 3 | 0.0003 |